Pfizer Beats on Q4 Earnings, Revenues, Outlook Disappoints
February 02, 2016 at 10:42 AM EST
While currency movement cut Pfizer’s fourth quarter revenues by 7% ($934 million), operational growth was 14% ($1.9 billion). International revenues declined 9% to $7.3 billion. Meanwhile, U.S. revenues grew 33% to $6.7 billion.
